Trial Profile
A study to assess tofacitnib for the treatment of Alopecia Areata and Variants in adolescents
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Nov 2016
Price :
$35
*
At a glance
- Drugs Tofacitinib (Primary)
- Indications Alopecia areata
- Focus Therapeutic Use
- 20 Nov 2016 New trial record
- 02 Nov 2016 Results published in the Journal of the American Academy of Dermatology